The results demonstrate that AE, when modified with myelin oligodendrocyte glycoprotein (MOG) peptide (AE/M), can confer antigen‐specific immune tolerance and promote regulatory T cells (Treg), thereby protecting mice from inflammatory symptoms in the experimental autoimmune encephalomyelitis model (Figure1). Here, MOG is linked to experimental autoimmune encephalomyelitis.